US · Healthcare · Medical Devices
EPS came in at 1.13 against a street estimate of 1.04 — a beat of 8.7%.
Analysts rate GE HealthCare Technologies Inc. a buy (16 buy, 5 hold, 0 sell out of 21) with an average price target of $82.50.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.97% |
| Dodge & Cox | 6.93% |
| Vanguard Capital Management, LLC | 6.39% |
| Capital Research Global Investors | 4.67% |
| State Street Corp | 4.55% |
| Vanguard Portfolio Management, LLC | 4.25% |
| Amvescap Plc. | 3.83% |
| Harris Associates L.P. | 3.45% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 | 2026-07-29 |
| Quarterly report · Q2 2026 | 2026-07-29 |
| Results announced · Q3 2026 | 2026-07-29 |
| Results announced · Q3 2026 | 2026-07-23 |
| Shareholder vote results · Q2 2026 | 2026-05-11 |
| Quarterly report · Q1 2026 | 2026-04-29 |
| Proxy statement · Q2 2026 | 2026-03-19 |
| Annual report FY2025 | 2026-02-04 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.04 / share ex-date Jul 24, 2026 · pay Aug 14, 2026 | 2026-07-24 |
| Dividend | $0.04 / share ex-date Apr 2, 2026 · pay May 15, 2026 | 2026-04-02 |
| Dividend | $0.04 / share ex-date Jan 9, 2026 · pay Feb 13, 2026 | 2026-01-09 |
| Dividend | $0.04 / share ex-date Oct 24, 2025 · pay Nov 14, 2025 | 2025-10-24 |
| Dividend | $0.04 / share ex-date Jul 25, 2025 · pay Aug 15, 2025 | 2025-07-25 |
| Announcement | Date |
|---|---|
| Debt offering to finance previously announced acquisition of Intelerad Medical Systems GE HealthCare Technologies issued $1.25 billion in senior notes to finance its acquisition of Intelerad Medical Systems. The company issued two tranches: $600 million in notes due 2028 at 4. | 2025-12-15 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for GE HealthCare Technologies Inc. — free to start.
Google PlayApp StoreData updated 2026-08-05.